41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
2150408
176282
2
Create a timeline
Public Timelines
For companies For educational institutions For teachers For students Dashboard
For educational institutions For teachers For students Dashboard
FAQ
Create a timeline
Public timelines
FAQ
About & FeedbackTermsPrivacyFAQ
Support 24/7  
DashboardGet premium
Donate

feb 23, 2012 - Ado-Trastuzumab Emtansine (T-DM1) Approved

Description:

FDA approves Ado-Trastuzumab Emtansine (T-DM1) for the treatment of patients with metastatic HER2-positive breast cancer. HER2 makes up 20% of all cases for breast cancer.

Added to timeline:

Cancer Timeline

ByGabriel Tackett
15 Nov 2018
0
0
367

Date:

feb 23, 2012
Now
~ 14 years ago
About & FeedbackTermsPrivacyFAQ
Support 24/7  
DashboardGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL